We are live on ! Find out more
RENEU

Cartesian Growth Corporation II Unit

Delisted

RENEU was delisted on the 19th of February, 2025.

15 hedge funds and large institutions have $23.9M invested in Cartesian Growth Corporation II Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 1815 (-3)

58% less capital invested

Capital invested by funds: $57.6M → $23.9M (-$33.6M)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change

RENEU Hedge Fund Activity: Q4 2022 in Review

15 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cartesian Growth Corporation II Unit (RENEU) for Q4 2022, worth a combined $23.9M — down 58% from $57.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RENEU and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.

The largest seller was Calamos Advisors, exiting entirely with an estimated $15.1M sold.

  • 15 institutional investors held Cartesian Growth Corporation II Unit (RENEU) as of Q4 2022, down from 18 in Q3 2022.
  • Funds reported $23.9M of Cartesian Growth Corporation II Unit stock for Q4 2022, down 58% quarter-over-quarter.
  • 1 fund opened new Cartesian Growth Corporation II Unit positions in Q4 2022 and 4 closed out, a net change of -3 holders.
  • The largest Cartesian Growth Corporation II Unit seller in Q4 2022 was Calamos Advisors, an estimated $15.1M sold.

Based on aggregated 13F filings for Q4 2022.